Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Alpha-linolenic acid (ALA) is an essential omega-3 fatty acid found in plant sources such as flaxseed, chia seeds, and walnuts. Its use in supporting or treating Inflammatory Bowel Disorders (IBD), such as Crohn’s disease and ulcerative colitis, is justified by a modest degree of scientific evidence, though not as robust as for long-chain omega-3s like EPA and DHA from fish oil. Some studies suggest that ALA and its metabolites exert anti-inflammatory effects by modulating the production of pro-inflammatory cytokines and eicosanoids. Animal models of colitis have demonstrated that diets rich in ALA or flaxseed oil can reduce intestinal inflammation and tissue damage. However, human clinical trials are limited and results are mixed; some small studies have shown reduced disease activity and inflammatory markers, while others found no significant benefit compared to placebo or standard therapy.

The mechanism is presumed to be related to ALA's conversion (albeit inefficient in humans) to longer-chain omega-3 fatty acids, which have better-documented anti-inflammatory effects. Additionally, ALA itself may have direct actions on cell membrane composition and inflammatory signaling pathways. Current guidelines do not recommend ALA supplementation as a standard therapy for IBD, but it is often considered as an adjunct to conventional treatment, particularly for patients seeking dietary approaches.

In summary, while there is some scientific rationale and preliminary data supporting the use of ALA in IBD, the overall quality and quantity of evidence remains insufficient for strong recommendations. More large-scale, well-controlled human trials are needed to clarify its therapeutic potential.

More about alpha-linolenic acid (ALA)
More about Inflammatory Bowel Disorders

Other ingredients used for Inflammatory Bowel Disorders

Other health conditions supported by alpha-linolenic acid (ALA)

Products containing alpha-linolenic acid (ALA)